@FierceMedDev: FDA: Kids with diabetes can use DexCom's continuous glucose monitor. Story | Follow @FierceMedDev
@MarkHFierce: Here's my perspective, as a patient, on the pacemaker industry. Editor's corner | Follow @MarkHFierce
@MichaelGFierce: Lupin stakes a claim on the sterile injectables market. News | Follow @MichaelGFierce
@EmilyWFierce: Endo waves goodbye to HealthTronics for $130M. Report | Follow @EmilyWFierce
> The Washington Post's "The Fact Checker" blog partially backs a claim by Sen. Tim Scott (R-SC) that the 2.3% medical device tax will cost small business owners $29 billion. Blog
> Minnesota-based Sansio, a med tech patient- management software business once owned by Medtronic ($MDT), has been sold to Physio-Control. Story
> Israel's Medigus has started selling a flexible endoscope that treats acid reflux without surgery. Story
> Direct Flow Medical gained a CE mark for what it bills as the first fully repositionable 29mm transcatheter aortic heart valve. Item
> Aurora Spine in California has obtained 510(k) clearance for sterile-packed titanium plasma spray-coated spinal fusion implants. Item
Biotech News
@FierceBiotech: Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success. More | Follow @FierceBiotech
@JohnCFierce: Furiex preps for buyout talks after IBS drug looks promising in PhIII. News | Follow @JohnCFierce
@DamianFierce: Big Pharma superteam joins NIH to share data, discover new drugs. Story | Follow @DamianFierce
@EmilyMFierce: Mechanism that boosts bone growth could aid osteoporosis drug design. Article via FierceBiotech Research | Follow @EmilyMFierce
> NEA backs $14M round for a biotech startup focused on autism disorder. More
> Acucela spots a $162M Japanese IPO to get its eye drug into focus. Read
Pharma News
@FiercePharma: Gilead in talks with Indian drugmakers to sell Sovaldi at cut-rate prices. Story | Follow @FiercePharma
@TracyStaton: From FiercePharmaMarketing: UCB nabs Asian marketing rights to hot Biogen MS drugs. More | Follow @TracyStaton
@EricPFierce: My colleague Mark Hollmer offers a thoughtful analysis of pacemakers after having one put in. Check it out. Item | Follow @EricPFierce
@CarlyHFierce: More Humira sales gains help AbbVie meet forecasts. News | Follow @CarlyHFierce
> Gilead in talks with Indian drugmakers to sell Sovaldi at cut-rate prices. More
> Bayer, Roche and GSK cancer meds win nod for special U.K. funding. News
> GlaxoSmithKline's Advair loses share to AstraZeneca's aggressive Symbicort discounts. Story
Biotech Research News
> $40M gift from stem cell agency will fund new genomics initiative. Item
> Exposure to acid turns adult cells into stem cells. More
> Merck halts drug testing on chimpanzees. News
> Mechanism that boosts bone growth could aid osteoporosis drug design. Report
> Stem cell signaling protein spurs cancer spread. Story
> Epilepsy drug reverses fatty liver disease in obese mice. Article
Pharma Manufacturing News
> Daiichi Sankyo is bringing the hammer down on Ranbaxy. More
> Amgen is halting Epogen manufacturing in Colorado. Story
> Abbott is closing a plant in Puerto Rico as Mexico's Neolpharma expands. Article
> Alexion buys vial-filling facility in Ireland. News
> Lupin stakes a claim on the sterile injectables market. Report
> Sources: Recipharm looks at doing an IPO to expand cash. Item